Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
04/2011
04/26/2011US7932276 administering a thiazole compounds with reduce side effect; 6-[2-(3,4-diethoxyphenyl)-thiazol-4-yl]pyridine-2-carboxylic acid
04/26/2011US7932274 3-indazolyl-4-pyridylisothiazoles
04/26/2011US7932246 Histone deacetylase inhibitors
04/26/2011CA2601458C Benzimidazolone derivatives as cb2 receptor ligands
04/26/2011CA2522577C Hepatitis c inhibitor compounds
04/26/2011CA2508474C Pesticidal sulphonylaminopyrazoles
04/26/2011CA2479133C 2-4-diaminopyrimidine derivatives
04/26/2011CA2477657C Cathepsin cysteine protease inhibitors
04/26/2011CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use
04/26/2011CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
04/21/2011WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011WO2011045415A2 New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
04/21/2011WO2011045271A1 Herbicidally active, heterocyclyl-substituted pyridazinones
04/21/2011WO2011045259A1 Aminopropenoates as fungicides
04/21/2011WO2011017347A3 Mesoionic pesticides
04/21/2011WO2010150281A3 Novel azabicyclohexanes
04/21/2011US20110092700 Novel Coumarin Derivative Having Antitumor Activity
04/21/2011US20110092698 Novel heterocyclyl compounds
04/21/2011US20110092695 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
04/21/2011US20110092555 Thiazolidinedione compound
04/21/2011US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use
04/21/2011US20110092528 Piperidinyl compounds that selectively bind integrins
04/21/2011US20110092524 Agent for Enhancing Corneal Epithelial Barrier Function
04/21/2011US20110092512 New hsl inhibitors useful in the treatment of diabetes
04/21/2011US20110092507 Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
04/21/2011US20110092505 Organic compounds
04/21/2011US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents
04/21/2011US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions
04/21/2011US20110092475 2-substituted-ethynylthiazole derivatives and uses of same
04/21/2011US20110092461 Pyridyl inhibitors of hedgehog signalling
04/21/2011US20110092423 INHIBITORS OF Akt ACTIVITY
04/21/2011US20110090338 Vehicular rearview mirror system
04/21/2011CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon
04/20/2011EP2311834A1 Crystal of thiazolidinedione compound, and process for production thereof
04/20/2011EP2311833A1 Tetomilast polymorphs
04/20/2011EP2311832A1 Tetomilast polymorphs
04/20/2011EP2311831A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
04/20/2011EP2311829A1 Substituted alkylamine derivatives and methods of use
04/20/2011EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
04/20/2011EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug
04/20/2011EP2311808A1 Substituted alkylamine derivatives and methods of use
04/20/2011EP2311807A1 Compounds and composition as protein kinase inhibitors
04/20/2011EP2311464A1 Agents for preventing and treating disorders involving modulation of the ryr receptors
04/20/2011EP2311455A1 Compounds for nonsense suppression, and methods for their use
04/20/2011EP2310386A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
04/20/2011EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
04/20/2011EP2310375A1 Chemical compounds
04/20/2011EP2310367A1 A process for the preparation of 4-ý2-(5-ethyl-2-pyridyl)ethoxy¨nitrobenzene and pioglitazone
04/20/2011EP2309857A2 Heterocyclic compounds used as pesticides
04/20/2011EP2227466B1 Heteroaryl-substituted piperidines
04/20/2011EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
04/20/2011EP1585739B1 Substituted arylcyclopropylacetamides as glucokinase activators
04/20/2011EP1505963B1 Hepatitis c virus inhibitors
04/20/2011EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
04/20/2011CN1834095B Nonnucleoside antivirus inhibitor, its preparation method and use
04/20/2011CN102027071A Azo metal chelate dye and optical recording medium
04/20/2011CN102026996A Pyridazine derivatives as factor XIA inhibitors
04/20/2011CN102026990A Novel inhibitors of hepatitis c virus replication
04/20/2011CN102026989A Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease
04/20/2011CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
04/20/2011CN102020522A Preparation method and application of deuterated drugs
04/20/2011CN101693202B Hydrogenation reaction catalyst of pioglitazone hydrochloride key intermediate and hydrogenation reaction method
04/20/2011CN101544633B Synthesis technology for methyl thiadiazole formamide
04/20/2011CN101235213B Light functional dye azo composite and preparation method thereof
04/20/2011CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses
04/20/2011CN101107246B Anti-trypanosomiasis agent
04/20/2011CN101039935B New piperidine antibiotics
04/19/2011US7928227 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
04/19/2011US7928137 Meta-benzamidine derivatives as serine protease inhibitors
04/19/2011US7928133 Compounds and compositions as hedgehog signaling pathway modulators
04/19/2011US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists
04/19/2011US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists
04/19/2011US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
04/19/2011US7927830 Modified carbocyanine dyes and their conjugates
04/19/2011CA2628963C Benzene derivative or salt thereof
04/19/2011CA2591257C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
04/19/2011CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor
04/19/2011CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents
04/19/2011CA2295625C Imidazole derivatives as mdr modulators
04/16/2011CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044001A1 Compounds and compositions as modulators of gpr119 activity
04/14/2011WO2011043480A1 Homocysteine synthase inhibitor
04/14/2011WO2011043479A1 Therapeutic agent for cerebral infarction
04/14/2011WO2011043404A1 Heterocyclic compound and its use for control of an arthropod pest
04/14/2011WO2011043371A1 Oxazole compound
04/14/2011WO2011042827A1 Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
04/14/2011WO2011042797A1 Pyrazole derivatives as modulators of calcium release -activated calcium channel
04/14/2011WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands
04/14/2011WO2011042473A2 Novel estrogen receptor ligands
04/14/2011WO2010006713A3 Heterocyclic compounds used as pesticides
04/14/2011US20110087030 Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
04/14/2011US20110086860 Compound
04/14/2011US20110086852 Pharmaceutical compounds
04/14/2011US20110086847 Thiadiazole modulators of beta adrenergic receptor
04/14/2011US20110086834 Alkynyl alcohols as kinase inhibitors
04/14/2011US20110086817 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
04/14/2011CA2776842A1 Pyrazole derivatives as modulators of calcium release-activated calcium channel
04/14/2011CA2774579A1 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use